Well Referenced

Tag: Helicobacter pylori

Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection

This 2016 observational retrospective study compared the efficacy of quadruple concomitant non-bismuth therapy (amoxicillin, clarithromycin, metronidazole, and a proton pump inhibitor) versus classical triple therapy (amoxicillin, clarithromycin, and a proton pump inhibitor) as first-line treatments for Helicobacter pylori infection. Among 510 patients treated between January 2012 and May 2014, the

Read More »
June 26, 2025 No Comments

Anti-parietal cell antibodies – diagnostic significance

This 2016 review article examines the clinical utility of anti-parietal cell antibodies (APCA) in diagnosing autoimmune atrophic gastritis (AAG) and pernicious anemia (PA). APCA target the H+/K+ ATPase proton pump in gastric parietal cells, primarily the alpha subunit. Detection methods include immunofluorescence, ELISA, and radioimmunoprecipitation assay (RIA), with RIA offering

Read More »
June 26, 2025 No Comments